Am J Obstet Gynecol

1. MEYER LA, Ishizawa S, Toumazis I
   Use of a Natural History Model to Benchmark Progress in Managing Ovarian Cancer (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00658.
   

   >> Share

   
   
2. MENG R
   Enhancing Clinical Translatability of Histology-Specific Ovarian Cancer Natural History Models (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00659.
   

   >> Share

   
   

   
   Cancer Lett

3. EL BABA R, Haidar Ahmad S, Vanhulle C, Vreux L, et al
   Formation of polyploid giant cancer cells and the transformative role of human cytomegalovirus IE1 protein.
   Cancer Lett. 2025;630:217824.
   

   >> Share

   
   

   
   Eur J Obstet Gynecol Reprod Biol

4. KHASTGIR G, Siwatch S, Singh T, Jain V, et al
   Beyond the Image: Performance of O-RADS, ADNEX, IOTA Simple Rules & RMI 4 in differentiating benign and malignant adnexal masses - An Indian perspective.
   Eur J Obstet Gynecol Reprod Biol. 2025;313:114585.
   

   >> Share

   
   
5. WANG Y, Wang T, Zhou H, Zhang Y, et al
   Oncological and reproductive outcomes of fertility-sparing surgery in young women with early-stage ovarian clear cell carcinoma: A retrospective cohort study.
   Eur J Obstet Gynecol Reprod Biol. 2025;313:114555.
   

   >> Share

   
   

   
   Gynecol Oncol

6. YOH K, Desai VB, Gross CP, Spatz ES, et al
   Physician variation in adopting opportunistic salpingectomy at the time of postpartum and interval sterilization for ovarian cancer risk reduction.
   Gynecol Oncol. 2025;202:1-13.
   

   >> Share

   
   

   
   Oncogene

7. HUANG L, Zhu M, Chen M, Ying F, et al
   LEF1 confers resistance to DNA-damaging chemotherapies through upregulation of PARP1 and NUMA1 in ovarian cancer.
   Oncogene. 2025 Sep 10. doi: 10.1038/s41388-025-03561.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share